[ad_1]
Campuzano V, Montermini L, Molto MD, Pianese L, Cossee M, Cavalcanti F, Monros E, Rodius F, Duclos F, Monticelli A, et al. Friedreich’s ataxia: autosomal recessive illness attributable to an intronic GAA triplet repeat growth. Science. 1996;271:1423–7.
Gerber J, Muhlenhoff U, Lill R. An interplay between frataxin and Isu1/Nfs1 that’s essential for Fe/S cluster synthesis on Isu1. EMBO Rep. 2003;4:906–11.
Stepanova A, Magrane J. Mitochondrial dysfunction in neurons in Friedreich’s ataxia. Mol Cell Neurosci. 2020;102:103419.
Koeppen AH, Davis AN, Morral JA. The cerebellar element of Friedreich’s ataxia. Acta Neuropathol. 2011;122:323–30.
Michael S, Petrocine SV, Qian J, Lamarche JB, Knutson MD, Garrick MD, Koeppen AH. Iron and iron-responsive proteins within the cardiomyopathy of Friedreich’s ataxia. Cerebellum. 2006;5:257–67.
Harding AE. Friedreich’s ataxia: a medical and genetic research of 90 households with an evaluation of early diagnostic standards and intrafamilial clustering of medical options. Mind. 1981;104:589–620.
Weidemann F, Rummey C, Bijnens B, Stork S, Jasaityte R, Dhooge J, Baltabaeva A, Sutherland G, Schulz JB, Meier T. Mitochondrial Safety with Idebenone in Cardiac or Neurological End result research g: The guts in Friedreich ataxia: definition of cardiomyopathy, illness severity, and correlation with neurological signs. Circulation. 2012;125:1626–34.
Raman SV, Phatak Ok, Hoyle JC, Pennell ML, McCarthy B, Tran T, Prior TW, Olesik JW, Lutton A, Rankin C, et al. Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome. Eur Coronary heart J. 2011;32:561–7.
Rajagopalan B, Francis JM, Cooke F, Korlipara LV, Blamire AM, Schapira AH, Madan J, Neubauer S, Cooper JM. Evaluation of the elements influencing the cardiac phenotype in Friedreich’s ataxia. Mov Disord. 2010;25:846–52.
Puccio H, Simon D, Cossee M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, Matyas R, Rustin P, Koenig M. Mouse fashions for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency adopted by intramitochondrial iron deposits. Nat Genet. 2001;27:181–6.
Seguin A, Santos R, Ache D, Dancis A, Camadro JM, Lesuisse E. Co-precipitation of phosphate and iron limits mitochondrial phosphate availability in Saccharomyces cerevisiae missing the yeast frataxin homologue (YFH1). J Biol Chem. 2011;286:6071–9.
Whitnall M, Suryo Rahmanto Y, Huang ML, Saletta F, Lok HC, Gutierrez L, Lazaro FJ, Fleming AJ, St Pierre TG, Mikhael MR, et al. Identification of nonferritin mitochondrial iron deposits in a mouse mannequin of Friedreich ataxia. Proc Natl Acad Sci U S A. 2012;109:20590–5.
Zhang SY, Napierala M, Napierala JS. Therapeutic prospects for Friedreich’s ataxia. Developments Pharmacol Sci. 2019;40:229–33.
Pandolfo M, Arpa J, Delatycki MB, Le Quan Sang KH, Mariotti C, Munnich A, Sanz-Gallego I, Tai G, Tarnopolsky MA, Taroni F, et al. Deferiprone in Friedreich ataxia: a 6-month randomized managed trial. Ann Neurol. 2014;76:509–21.
Parkinson MH, Schulz JB, Giunti P. Co-enzyme Q10 and idebenone use in Friedreich’s ataxia. J Neurochem. 2013;126(Suppl 1):125–41.
Feng L, Dou C, Xia Y, Li B, Zhao M, Yu P, Zheng Y, El-Toni AM, Atta NF, Galal A, et al. Neutrophil-like Cell-Membrane-Coated Nanozyme Remedy for Ischemic Mind Injury and Lengthy-Time period Neurological Practical Restoration. ACS Nano. 2021;15:2263–80.
Cai X, Zhang Ok, Xie X, Zhu X, Feng J, Jin Z, Zhang H, Tian M, Chen H. Self-assembly hole manganese Prussian white nanocapsules attenuate Tau-related neuropathology and cognitive decline. Biomaterials. 2020;231:119678.
Hou W, Ye C, Chen M, Gao W, Xie X, Wu J, Zhang Ok, Zhang W, Zheng Y, Cai X. Excavating bioactivities of nanozyme to transform microenvironment for safeguarding chondrocytes and delaying osteoarthritis. Bioact Mater. 2021;6:2439–51.
Zhang Y, Yin Y, Zhang W, Li H, Wang T, Yin H, Solar L, Su C, Zhang Ok, Xu H. Reactive oxygen species scavenging and irritation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis. J Nanobiotechnology. 2021;19:161.
Monroy A, Lithgow GJ, Alavez S. Curcumin and neurodegenerative illnesses. BioFactors. 2013;39:122–32.
Jiao Y, Wilkinson JT, Christine Pietsch E, Buss JL, Wang W, Planalp R, Torti FM, Torti SV. Iron chelation within the organic exercise of curcumin. Free Radic Biol Med. 2006;40:1152–60.
Sharifi S, Fathi N, Memar MY, Hosseiniyan Khatibi SM, Khalilov R, Negahdari R, Zununi Vahed S, Maleki Dizaj S. Anti-microbial exercise of curcumin nanoformulations: New developments and future views. Phytother Res. 2020;34:1926–46.
Zhang Ok, Tu M, Gao W, Cai X, Music F, Chen Z, Zhang Q, Wang J, Jin C, Shi J, et al. Hole prussian blue nanozymes drive neuroprotection towards ischemic stroke by way of attenuating oxidative stress, counteracting irritation, and suppressing cell apoptosis. Nano Lett. 2019;19:2812–23.
Feng LS, Dou CR, Xia YG, Li BH, Zhao MY, El-Toni AM, Atta NF, Zheng YY, Cai XJ, Wang Y, et al. Enhancement of nanozyme permeation by endovascular interventional remedy to stop vascular restenosis by way of macrophage polarization modulation. Adv Funct Mater. 2020. https://doi.org/10.1002/adfm.202006581.
Qu J, Zhao X, Liang Y, Zhang T, Ma PX, Guo B. Antibacterial adhesive injectable hydrogels with speedy self-healing, extensibility and compressibility as wound dressing for joints pores and skin wound therapeutic. Biomaterials. 2018;183:185–99.
Cao H, Duan L, Zhang Y, Cao J, Zhang Ok. Present hydrogel advances in physicochemical and organic response-driven biomedical utility variety. Sign Transduct Goal Ther. 2021;6:426.
Alibolandi M, Mohammadi M, Taghdisi SM, Ramezani M, Abnous Ok. Fabrication of aptamer embellished dextran coated nano-graphene oxide for focused drug supply. Carbohydr Polym. 2017;155:218–29.
Wang Z, Hao Z, Yu S, De Moraes CG, Suh LH, Zhao X, Lin Q. An Ultraflexible and Stretchable Aptameric Graphene Nanosensor for Biomarker Detection and Monitoring. Adv Funct Mater. 2019. https://doi.org/10.1002/adfm.201905202.
Mottaghitalab F, Farokhi M, Shokrgozar MA, Atyabi F, Hosseinkhani H. Silk fibroin nanoparticle as a novel drug supply system. J Management Launch. 2015;206:161–76.
Tian Y, Jiang X, Chen X, Shao Z, Yang W. Doxorubicin-loaded magnetic silk fibroin nanoparticles for focused remedy of multidrug-resistant most cancers. Adv Mater. 2014;26:7393–8.
Zhang L, Xu L, Li G, Yang Y. Fabrication of high-strength mecobalamin loaded aligned silk fibroin scaffolds for guiding neuronal orientation. Colloids Surf B Biointerfaces. 2019;173:689–97.
Li H, Liu Y, Shang L, Cai J, Wu J, Zhang W, Pu X, Dong W, Qiao T, Li Ok. Iron regulatory protein 2 modulates the swap from cardio glycolysis to oxidative phosphorylation in mouse embryonic fibroblasts. Proc Natl Acad Sci U S A. 2019;116:9871–6.
Liu Y, Cai J, Shen J, Dong W, Xu L, Fang M, Lin Y, Liu J, Ding Y, Qiao T, Li Ok. SS-31 efficacy in a mouse mannequin of Friedreich ataxia by upregulation of frataxin expression. Hum Mol Genet. 2021. https://doi.org/10.1093/hmg/ddab232.
Beneduci A, Corrente GA, Marino T, Aiello D, Bartella L, Di Donna L, Napoli A, Russo N, Romeo I, Furia E. Perception on the chelation of aluminum(III) and iron(III) by curcumin in aqueous resolution. J Mol Liq. 2019. https://doi.org/10.1016/j.molliq.2019.111805.
Rainey NE, Moustapha A, Saric A, Nicolas G, Sureau F, Petit PX. Iron chelation by curcumin suppresses each curcumin-induced autophagy and cell dying along with iron overload neoplastic transformation. Cell Dying Discov. 2019. https://doi.org/10.1038/s41420-019-0234-y.
Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014;19:20091–112.
Solar YX, Shi FF, Niu YJ, Zhang Y, Xiong F. Fe3O4@OA@Poloxamer nanoparticles decrease triglyceride in hepatocytes by way of liposuction impact and nano-enzyme impact. Colloids Surf B-Biointerfaces. 2019. https://doi.org/10.1016/j.colsurfb.2019.110528.
Solar Y, Xu L, Liu X, Shen Y, Zhang Y, Gu N, Xiong F. Coronal relay reactor Fe3O4@CeO2 for accelerating ROS axial conversion by way of enhanced Enzyme-like impact and relay impact. Chem Eng J. 2022. https://doi.org/10.1016/j.cej.2021.132303.
Mandel S, Amit T, Bar-Am O, Youdim MBH. Iron dysregulation in Alzheimer’s illness: Multimodal mind permeable iron chelating medicine, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory actions as therapeutic brokers. Prog Neurobiol. 2007;82:348–60.
Tiwari SK, Agarwal S, Seth B, Yadav A, Nair S, Bhatnagar P, Karmakar M, Kumari M, Chauhan LKS, Patel DK, et al. Curcumin-loaded nanoparticles potently induce grownup neurogenesis and reverse cognitive deficits in alzheimer’s illness mannequin by way of canonical wnt/beta-catenin pathway. ACS Nano. 2014;8:76–103.
Ward RJ, Dexter DT, Crichton RR. Neurodegenerative illnesses and therapeutic methods utilizing iron chelators. J Hint Elem Med Biol. 2015;31:267–73.
Anjomani Virmouni S, Sandi C, Al-Mahdawi S, Pook MA. Mobile, molecular and practical characterisation of YAC transgenic mouse fashions of Friedreich ataxia. PLoS ONE. 2014;9:e107416.
Solar Y, Liu X, Wang L, Xu L, Liu Ok, Xu L, Shi F, Zhang Y, Gu N, Xiong F. Excessive-performance SOD mimetic enzyme Au@Ce for arresting cell cycle and proliferation of acute myeloid leukemia. Bioact Mater. 2022;10:117–30.
Xie X, Zhao J, Gao W, Chen J, Hu B, Cai X, Zheng Y. Prussian blue nanozyme-mediated nanoscavenger ameliorates acute pancreatitis by way of inhibiting TLRs/NF-kappaB signaling pathway. Theranostics. 2021;11:3213–28.
Garufi A, Baldari S, Pettinari R, Gilardini Montani MS, D’Orazi V, Pistritto G, Crispini A, Giorno E, Toietta G, Marchetti F, et al. A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the most cancers cell dying/survival end result based on p53 standing. J Exp Clin Most cancers Res. 2020;39:122.
Ma CS, Lv QM, Zhang KR, Tang YB, Zhang YF, Shen Y, Lei HM, Zhu L. NRF2-GPX4/SOD2 axis imparts resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung most cancers cells. Acta Pharmacol Sin. 2021;42:613–23.
Lin XY, Bai DP, Wei ZX, Zhang Y, Huang YF, Deng H, Huang XH. Curcumin attenuates oxidative stress in RAW264.7 cells by growing the exercise of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PLoS ONE. 2019. https://doi.org/10.1371/journal.pone.0216711.
Zhang W, Xu L, Zhao H, Li Ok. Mammalian mitochondrial iron–sulfur cluster biogenesis and switch and associated human illnesses. Biophysics Stories. 2021;7:127–41.
Delatycki MB, Bidichandani SI. Friedreich ataxia- pathogenesis and implications for therapies. Neurobiol Dis. 2019;132:104606.
Lynch DR, Farmer G. Mitochondrial and metabolic dysfunction in Friedreich ataxia: replace on pathophysiological relevance and medical interventions. Neuronal Sign. 2021. https://doi.org/10.1042/NS20200093.
Lynch DR, Chin MP, Delatycki MB, Subramony SH, Corti M, Hoyle JC, Boesch S, Nachbauer W, Mariotti C, Mathews KD, et al. Security and efficacy of omaveloxolone in Friedreich ataxia (MOXIe Research). Ann Neurol. 2021;89:212–25.
Li Ok. Iron pathophysiology in Friedreich’s ataxia. Adv Exp Med Biol. 2019;1173:125–43.
Shin JW, Chun KS, Kim DH, Kim SJ, Kim SH, Cho NC, Na HK, Surh YJ. Curcumin induces stabilization of Nrf2 protein by way of Keap1 cysteine modification. Biochem Pharmacol. 2020;173:113820.
Yan Y, Chen Y, Liu Z, Cai F, Niu W, Music L, Liang H, Su Z, Yu B, Yan F. Mind supply of curcumin by way of low-intensity ultrasound-induced blood-brain barrier opening by way of lipid-PLGA nanobubbles. Int J Nanomedicine. 2021;16:7433–47.
Zhao W, Yu XR, Peng SJ, Luo Y, Li JC, Lu LG. Development of nanomaterials as distinction brokers or probes for glioma imaging. J Nanobiotechnol. 2021. https://doi.org/10.1186/s12951-021-00866-9.
Li J, Yu X, Jiang Y, He S, Zhang Y, Luo Y, Pu Ok. Second near-infrared photothermal semiconducting polymer nanoadjuvant for enhanced most cancers immunotherapy. Adv Mater. 2021;33:e2003458.
Fang Y, Li HY, Yin HH, Xu SH, Ren WW, Ding SS, Tang WZ, Xiang LH, Wu R, Guan X, Zhang Ok. Radiofrequency-sensitive longitudinal leisure tuning technique enabling the visualization of radiofrequency ablation intensified by magnetic composite. ACS Appl Mater Interfaces. 2019;11:11251–61.
Bhat A, Mahalakshmi AM, Ray B, Tuladhar S, Hediyal TA, Manthiannem E, Padamati J, Chandra R, Chidambaram SB, Sakharkar MK. Advantages of curcumin in mind problems. BioFactors. 2019;45:666–89.
Sundaram JR, Poore CP, Sulaimee NHB, Pareek T, Cheong WF, Wenk MR, Pant HC, Frautschy SA, Low CM, Kesavapany S. Curcumin ameliorates neuroinflammation, neurodegeneration, and reminiscence deficits in p25 transgenic mouse mannequin that bears hallmarks of Alzheimer’s illness. J Alzheimers Dis. 2017;60:1429–42.
[ad_2]
